uracil has been researched along with Recrudescence in 43 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Excerpt | Relevance | Reference |
|---|---|---|
| "To establish the sufficient therapy for elderly colorectal cancer patients, we retrospectively compared postoperative Tegafur/Uracil (UFT; Taiho Pharmaceutical Co." | 7.75 | Efficacy of postoperative UFT (Tegafur/Uracil) plus PSK therapies in elderly patients with resected colorectal cancer. ( Takashima, S; Yoshitani, S, 2009) |
| "We report two cases of recurrent colorectal cancer in two patients who were treated successfully with a combined oral chemotherapeutic agent folinate/tegafur/uracil (UFT/LV) dosage." | 7.74 | [Two cases of recurrent colorectal cancer treated successfully with folinate/tegafur/uracil (UFT/LV) chemotherapy on an outpatient basis]. ( Hosotaki, K; Shimamoto, M; Tabira, Y; Tamori, Y, 2008) |
| "Ninety-one patients with metastatic breast cancer who had been previously treated with anthracyclines and/or taxanes were treated with UFT and leucovorin, given orally, for the first 28 days of a 35-day cycle." | 6.75 | A phase 2 study of a fixed combination of uracil and ftorafur (UFT) and leucovorin given orally in a 3-times-daily regimen to treat patients with recurrent metastatic breast cancer. ( Booser, DJ; Heim, W; Hortobagyi, GN; Hutchins, L; Kirshner, J; Mason, B; Rivera, E, 2010) |
| "Ninety-four patients with metastatic breast cancer who had been previously treated with anthracyclines and/or taxanes were treated with UFT and leucovorin, given orally, for the first 28 days of a 35-day cycle." | 6.75 | A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic breast cancer. ( Gore, I; Hermann, R; Hortobagyi, GN; Ibrahim, NK; Karwal, M; Murray, JL; Watkins, SP; Young, RR, 2010) |
| "The purpose of this study is to evaluate the efficacy of postoperative adjuvant chemotherapy using uracil and tegafur (UFT) for colorectal cancer." | 5.10 | Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial. ( Baba, S; Hasumi, A; Kato, T; Koike, A; Manabe, T; Maruta, M; Miura, K; Nakazato, H; Nimura, Y; Ohashi, Y; Saji, S; Suzuki, H; Takagi, H; Yamaguchi, A, 2002) |
| "A 40-year-old man, diagnosed with decompensated liver cirrhosis because of hepatitis C virus, was on the wait list for a liver transplant when he began treatment with the direct-acting antivirals simeprevir 150 mg and sofosbuvir 400 mg." | 3.83 | First Case in Kazakhstan of Successful Therapy With 2 Consecutive Direct-Acting Antiviral Regimens in a Patient with Hepatitis C Virus-Induced Decompensated Liver Cirrhosis on a Liver Transplant Wait List. ( Ashimkhanova, A; Kaliaskarova, K; Yesmembetov, K, 2016) |
| "To establish the sufficient therapy for elderly colorectal cancer patients, we retrospectively compared postoperative Tegafur/Uracil (UFT; Taiho Pharmaceutical Co." | 3.75 | Efficacy of postoperative UFT (Tegafur/Uracil) plus PSK therapies in elderly patients with resected colorectal cancer. ( Takashima, S; Yoshitani, S, 2009) |
| "Here, we present a case of recurrent hepatocellular carcinoma(HCC)with portal thrombus that disappeared within only two months by oral tegafur(UFT-E)." | 3.75 | [A case report--complete disappearance of multiple intrahepatic recurrences and portal thrombus in a case of hepatocellular carcinoma treated with UFT-E]. ( Anegawa, G; Hayashi, H; Inoue, F; Sonoda, H, 2009) |
| "We report two cases of recurrent colorectal cancer in two patients who were treated successfully with a combined oral chemotherapeutic agent folinate/tegafur/uracil (UFT/LV) dosage." | 3.74 | [Two cases of recurrent colorectal cancer treated successfully with folinate/tegafur/uracil (UFT/LV) chemotherapy on an outpatient basis]. ( Hosotaki, K; Shimamoto, M; Tabira, Y; Tamori, Y, 2008) |
| "Early after an ACS, patients with type 2 diabetes mellitus experience a significant burden of HF events and recurrent ACS." | 2.87 | Early and Chronic Dipeptidyl-Peptidase-IV Inhibition and Cardiovascular Events in Patients With Type 2 Diabetes Mellitus After an Acute Coronary Syndrome: A Landmark Analysis of the EXAMINE Trial. ( Bakris, GL; Cannon, CP; Cushman, WC; Liu, Y; Sharma, A; White, WB; Zannad, F, 2018) |
| "Ninety-one patients with metastatic breast cancer who had been previously treated with anthracyclines and/or taxanes were treated with UFT and leucovorin, given orally, for the first 28 days of a 35-day cycle." | 2.75 | A phase 2 study of a fixed combination of uracil and ftorafur (UFT) and leucovorin given orally in a 3-times-daily regimen to treat patients with recurrent metastatic breast cancer. ( Booser, DJ; Heim, W; Hortobagyi, GN; Hutchins, L; Kirshner, J; Mason, B; Rivera, E, 2010) |
| "Ninety-four patients with metastatic breast cancer who had been previously treated with anthracyclines and/or taxanes were treated with UFT and leucovorin, given orally, for the first 28 days of a 35-day cycle." | 2.75 | A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic breast cancer. ( Gore, I; Hermann, R; Hortobagyi, GN; Ibrahim, NK; Karwal, M; Murray, JL; Watkins, SP; Young, RR, 2010) |
| "In addition, remote metastases tended to be suppressed for both colon and rectal cancer in Group A (p=0." | 2.71 | Pre- and post-operative adjuvant chemotherapy in colorectal cancer. ( Isomoto, H; Kakegawa, T; Mori, M; Nakagoe, T; Ogawa, M; Sugimachi, K; Takano, S; Tomita, M; Yamada, K, 2003) |
| "The patient is alive and well without recurrence for more than 10years after lung resection." | 2.55 | [A Case of Recurrent Rectal Cancer with Adrenal and Lung Metastasis with More than Ten-Year Survival after Surgery]. ( Fuse, T; Katarao, Y; Kimura, Y; Shimizu, Y; Takemura, M; Tanaka, R; Uchiyama, K; Yamamoto, Y, 2017) |
| " However, there are limited clinical reports of long-term administration of TAS-102." | 1.48 | [Two Cases of Long-Term Use of TAS-102 for Unresectable Colorectal Cancer]. ( Kinoshita, H; Miki, A; Nakamura, D; Sugiyama, T; Tsubono, M; Uchida, S, 2018) |
| "Peritoneal metastasis of breast cancer was suspected, and an operation was performed for a definitive diagnosis." | 1.42 | [A Case of Peritoneal Metastasis of Breast Cancer Diagnosed by Laparoscopic-Assisted Right Hemicolectomy]. ( Egawa, C; Goto, T; Hashimoto, T; Ishida, T; Kagawa, Y; Kato, T; Katsura, Y; Kimura, K; Kusama, H; Matsushita, K; Morimoto, Y; Motoyama, Y; Murakami, K; Nagano, T; Naito, A; Nakatsuka, S; Nitta, K; Ohmura, Y; Ohneda, Y; Okishiro, M; Sakisaka, H; Sato, Y; Takatsuka, Y; Takeda, Y; Takeno, A; Tamura, S; Taniguchi, H, 2015) |
| "We reported the successful treatment of relapsed 6q24-related TNDM with a DPP4 inhibitor." | 1.40 | Relapsing 6q24-related transient neonatal diabetes mellitus successfully treated with a dipeptidyl peptidase-4 inhibitor: a case report. ( Fujii, M; Fujimaru, R; Hashimoto, Y; Hatake, K; Hosokawa, Y; Kawakita, R; Nakajima, H; Tamagawa, N; Yorifuji, T, 2014) |
| "The tegafur-uracil treatment resulted in the disappearance of pulmonary metastases, and a stabilization of the bone metastases." | 1.40 | [A case of recurrent lung cancer with bone metastases treated with tegafur-uracil and zoledronic acid for long-term survival]. ( Abiko, M; Harada, M; Sato, T; Shiono, S; Takanashi, I, 2014) |
| "Between 2003 and 2009, 273 stage III colon cancer patients underwent surgery in our institute, and we studied 156 of them." | 1.38 | [A retrospective study of UFT and oral leucovorin plus PSK combination adjuvant chemotherapy in patients with stage III colon cancer]. ( Hanaoka, Y; Hashimoto, M; Kumamoto, T; Kuroyanagi, H; Matoba, S; Moriyama, J; Sawada, T; Toda, S; Tomizawa, K; Udagawa, H; Watanabe, G, 2012) |
| "Herein, we report a bladder cancer case with multiple metastases which were controlled by low-dose UFT." | 1.37 | [A case of marked efficacy of low-dose UFT against metastatic bladder cancer]. ( Arai, Y; Ito, A; Kuwahara, M; Nakano, O; Satoh, M, 2011) |
| "He has been well without any sign of recurrence or elevation of tumor markers for 2 years." | 1.36 | [Successful management with S-1 of recurrent gastric cancer after adjuvant chemotherapy with paclitaxel/UFT]. ( Saito, T; Sasaki, H; Tokunaga, Y, 2010) |
| " The urinary uracil value reflecting DPD activity of the whole body could be used as an index of recurrence at the time of long-term dosage of S-1." | 1.35 | [Study of a relationship between a change in the urinary uracil value after a S-1 long-term administration and the recurrence of stomach cancer]. ( Akiyama, I; Fujita, Y; Hasegawa, K; Morimoto, S; Shono, Y; Tabuse, K; Tsuji, T, 2008) |
| " Although topical corticosteroids have been widely utilized in steroid-responsive dermatoses such as AD, their chronic use may be associated with significant side effects." | 1.32 | Inhibitory activity of CX-659S, a novel diaminouracil derivative, against the rebound phenomenon following withdrawal of corticosteroid therapy for chronic contact hypersensitivity responses. ( Hayashi, H; Inoue, Y; Isobe, M; Shiohara, T, 2003) |
| "Three types of anal fissures are established." | 1.30 | [Acute anal fissures in puerperants]. ( Sariev, AA, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (23.26) | 18.7374 |
| 1990's | 4 (9.30) | 18.2507 |
| 2000's | 9 (20.93) | 29.6817 |
| 2010's | 20 (46.51) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uchiyama, K | 1 |
| Katarao, Y | 1 |
| Kimura, Y | 1 |
| Tanaka, R | 1 |
| Fuse, T | 1 |
| Takemura, M | 1 |
| Yamamoto, Y | 1 |
| Shimizu, Y | 1 |
| Minichini, C | 1 |
| Starace, M | 1 |
| De Pascalis, S | 1 |
| Macera, M | 1 |
| Occhiello, L | 1 |
| Caroprese, M | 1 |
| Vitrone, M | 1 |
| Iovinella, V | 1 |
| Guerrera, B | 1 |
| Masarone, M | 1 |
| Coppola, N | 1 |
| Sharma, A | 1 |
| Cannon, CP | 1 |
| White, WB | 1 |
| Liu, Y | 1 |
| Bakris, GL | 1 |
| Cushman, WC | 1 |
| Zannad, F | 1 |
| Sugiyama, T | 1 |
| Miki, A | 1 |
| Nakamura, D | 1 |
| Kinoshita, H | 1 |
| Uchida, S | 1 |
| Tsubono, M | 1 |
| Chestnova, TV | 1 |
| Zilov, VG | 1 |
| Gladkikh, PG | 1 |
| Khadartsev, AA | 1 |
| Korotkova, AS | 1 |
| Buzulukov, YP | 1 |
| Yorifuji, T | 1 |
| Hashimoto, Y | 1 |
| Kawakita, R | 1 |
| Hosokawa, Y | 1 |
| Fujimaru, R | 1 |
| Hatake, K | 1 |
| Tamagawa, N | 1 |
| Nakajima, H | 1 |
| Fujii, M | 1 |
| Fushimi, K | 1 |
| Tanabe, N | 1 |
| Takami, M | 1 |
| Shiono, S | 1 |
| Harada, M | 1 |
| Abiko, M | 1 |
| Sato, T | 1 |
| Takanashi, I | 1 |
| Poordad, F | 1 |
| Agarwal, K | 1 |
| Younes, Z | 1 |
| Cohen, D | 1 |
| Xie, W | 1 |
| Podsadecki, T | 1 |
| Sollima, S | 1 |
| Milazzo, L | 1 |
| Torre, A | 1 |
| Calvi, E | 1 |
| Regalia, E | 1 |
| Antinori, S | 1 |
| Saab, S | 1 |
| Gonzalez, YS | 1 |
| Huber, C | 1 |
| Wang, A | 1 |
| Juday, T | 1 |
| Sato, Y | 1 |
| Okishiro, M | 1 |
| Ohneda, Y | 1 |
| Motoyama, Y | 1 |
| Ishida, T | 1 |
| Morimoto, Y | 1 |
| Kusama, H | 1 |
| Matsushita, K | 1 |
| Hashimoto, T | 1 |
| Kimura, K | 1 |
| Naito, A | 1 |
| Murakami, K | 1 |
| Katsura, Y | 1 |
| Nitta, K | 1 |
| Ohmura, Y | 1 |
| Kagawa, Y | 1 |
| Takeno, A | 1 |
| Sakisaka, H | 1 |
| Taniguchi, H | 1 |
| Egawa, C | 1 |
| Takeda, Y | 1 |
| Kato, T | 2 |
| Tamura, S | 1 |
| Takatsuka, Y | 1 |
| Goto, T | 1 |
| Nagano, T | 1 |
| Nakatsuka, S | 1 |
| Yesmembetov, K | 1 |
| Ashimkhanova, A | 1 |
| Kaliaskarova, K | 1 |
| Morimoto, S | 1 |
| Tsuji, T | 1 |
| Shono, Y | 1 |
| Akiyama, I | 1 |
| Fujita, Y | 1 |
| Hasegawa, K | 1 |
| Tabuse, K | 1 |
| Yoshitani, S | 1 |
| Takashima, S | 1 |
| Hayashi, H | 2 |
| Anegawa, G | 1 |
| Sonoda, H | 1 |
| Inoue, F | 1 |
| Sakurai, T | 2 |
| Umemura, T | 1 |
| Jinta, E | 1 |
| Suzuma, T | 1 |
| Yoshimura, G | 1 |
| Shimizu, S | 1 |
| Hortobagyi, GN | 2 |
| Heim, W | 1 |
| Hutchins, L | 1 |
| Rivera, E | 1 |
| Mason, B | 1 |
| Booser, DJ | 1 |
| Kirshner, J | 1 |
| Young, RR | 1 |
| Karwal, M | 1 |
| Ibrahim, NK | 1 |
| Hermann, R | 1 |
| Murray, JL | 1 |
| Watkins, SP | 1 |
| Gore, I | 1 |
| FROMMEYER, WB | 1 |
| SPIES, TD | 1 |
| Tokunaga, Y | 1 |
| Sasaki, H | 1 |
| Saito, T | 1 |
| Takashima, T | 1 |
| Tayama, Y | 1 |
| Nakamura, Y | 1 |
| Hirata, K | 1 |
| Satoh, M | 1 |
| Nakano, O | 1 |
| Kuwahara, M | 1 |
| Ito, A | 1 |
| Arai, Y | 1 |
| Sakamoto, Y | 1 |
| Murata, A | 1 |
| Koyama, M | 1 |
| Morohashi, H | 1 |
| Tsutsumi, S | 1 |
| Yonaiyama, S | 1 |
| Morita, T | 1 |
| Hakamada, K | 1 |
| Tomizawa, K | 1 |
| Kumamoto, T | 1 |
| Hanaoka, Y | 1 |
| Toda, S | 1 |
| Moriyama, J | 1 |
| Matoba, S | 1 |
| Kuroyanagi, H | 1 |
| Hashimoto, M | 1 |
| Udagawa, H | 1 |
| Watanabe, G | 1 |
| Sawada, T | 1 |
| Inoue, Y | 1 |
| Isobe, M | 1 |
| Shiohara, T | 1 |
| Isomoto, H | 1 |
| Tomita, M | 1 |
| Sugimachi, K | 1 |
| Ogawa, M | 1 |
| Yamada, K | 1 |
| Nakagoe, T | 1 |
| Mori, M | 1 |
| Takano, S | 1 |
| Kakegawa, T | 1 |
| Hosotaki, K | 1 |
| Tabira, Y | 1 |
| Shimamoto, M | 1 |
| Tamori, Y | 1 |
| Salekh, BS | 1 |
| Cromby, CH | 1 |
| Manning, NJ | 1 |
| Pollitt, RJ | 1 |
| Powell, S | 1 |
| Bennett, MJ | 1 |
| Nakamoto, T | 1 |
| Igawa, M | 1 |
| Usui, T | 1 |
| Sariev, AA | 1 |
| Malyshev, KV | 1 |
| Ohashi, Y | 1 |
| Nakazato, H | 1 |
| Koike, A | 1 |
| Saji, S | 1 |
| Suzuki, H | 1 |
| Takagi, H | 1 |
| Nimura, Y | 1 |
| Hasumi, A | 1 |
| Baba, S | 1 |
| Manabe, T | 1 |
| Maruta, M | 1 |
| Miura, K | 1 |
| Yamaguchi, A | 1 |
| Lomazova, MM | 2 |
| Kabkalo, DN | 1 |
| Skripkin, IuK | 1 |
| Khamaganova, AV | 1 |
| Kriazheva, SS | 1 |
| Iartsev, MN | 1 |
| Komel', GI | 1 |
| Gomes, LA | 1 |
| Gel'berg, IS | 1 |
| Romaniuk, SL | 1 |
| Avlasenko, VS | 1 |
| Zharovina, MM | 1 |
| Glavinskaia, TA | 2 |
| Frigo, NV | 2 |
| Novikova, SI | 1 |
| Rezaĭkina, AV | 2 |
| Borisenko, KK | 1 |
| Lezvinskaia, EM | 1 |
| Basinskaia, NM | 1 |
| Mikheev, NA | 1 |
| Pavlovskaia, VE | 1 |
| Grachev, BG | 1 |
| Khlestkov, AA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome[NCT00968708] | Phase 3 | 5,380 participants (Actual) | Interventional | 2009-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Primary Major Adverse Cardiac Events were defined as a composite of cardiovascular death, nonfatal myocardial infarction and nonfatal stroke; these events were adjudicated by an independent cardiovascular endpoints committee. (NCT00968708)
Timeframe: From randomization until the adjudication cut-off date of May 31 2013 (maximum time on study was 41 months).
| Intervention | percentage of participants (Number) |
|---|---|
| Placebo | 11.8 |
| Alogliptin | 11.3 |
Secondary MACE composite consisted of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, or urgent revascularization due to unstable angina; these events were adjudicated by an independent cardiovascular endpoint committee. (NCT00968708)
Timeframe: From randomization until the adjudication cut-of date of May 31 2013 (maximum time on study was 41 months).
| Intervention | percentage of participants (Number) |
|---|---|
| Placebo | 13.4 |
| Alogliptin | 12.7 |
1 review available for uracil and Recrudescence
| Article | Year |
|---|---|
[A Case of Recurrent Rectal Cancer with Adrenal and Lung Metastasis with More than Ten-Year Survival after Surgery].
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Chemotherap | 2017 |
6 trials available for uracil and Recrudescence
| Article | Year |
|---|---|
Early and Chronic Dipeptidyl-Peptidase-IV Inhibition and Cardiovascular Events in Patients With Type 2 Diabetes Mellitus After an Acute Coronary Syndrome: A Landmark Analysis of the EXAMINE Trial.
Topics: Acute Coronary Syndrome; Aged; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double | 2018 |
A phase 2 study of a fixed combination of uracil and ftorafur (UFT) and leucovorin given orally in a 3-times-daily regimen to treat patients with recurrent metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dr | 2010 |
A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic breast cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 2010 |
Pre- and post-operative adjuvant chemotherapy in colorectal cancer.
Topics: Aged; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Female; Humans; Male; Mid | 2003 |
Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Colorecta | 2002 |
[Controlled randomized clinical trials of immunomodulators diucifon and sodium nucleinate in children with recurrent suppurative infections].
Topics: Adjuvants, Immunologic; Adolescent; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Child; Chi | 1991 |
36 other studies available for uracil and Recrudescence
| Article | Year |
|---|---|
HCV genotype-3h, a difficult-to-diagnose sub-genotype in the DAA era.
Topics: 2-Naphthylamine; Aged; Amino Acid Substitution; Anilides; Antiviral Agents; Carbamates; Cyclopropane | 2018 |
[Two Cases of Long-Term Use of TAS-102 for Unresectable Colorectal Cancer].
Topics: Aged, 80 and over; Appendiceal Neoplasms; Drug Combinations; Female; Humans; Male; Pyrrolidines; Rec | 2018 |
Combined Effect of Silver Nanoparticles, Ceftriaxone, and Methyluracil during Experimental Purulent Peritonitis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Ceftriaxone; Infectious Disease Medicine; Inflammation; Ma | 2018 |
Relapsing 6q24-related transient neonatal diabetes mellitus successfully treated with a dipeptidyl peptidase-4 inhibitor: a case report.
Topics: Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Male; Piperidine | 2014 |
[A retrospective study of tegafur/uracil compared with cyclophosphamide, methotrexate, and fluorouracil as adjuvant chemotherapy in patients with node-negative, triple-negative breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamid | 2014 |
[A case of recurrent lung cancer with bone metastases treated with tegafur-uracil and zoledronic acid for long-term survival].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Diphosphonates; H | 2014 |
Low relapse rate leads to high concordance of sustained virologic response (SVR) at 12 weeks with SVR at 24 weeks after treatment with ABT-450/ritonavir, ombitasvir, and dasabuvir plus ribavirin in subjects with chronic hepatitis C virus genotype 1 infect
Topics: 2-Naphthylamine; Adult; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Resistance, Vira | 2015 |
Paritaprevir/ritonavir, ombitasvir, and dasabuvir for treatment of recurrent hepatitis C virus infection in the human immunodeficiency virus coinfected liver transplant recipient.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Coinfection; Cyclopropanes; Drug Therapy, C | 2016 |
Cost-effectiveness of Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir+Ribavirin for US Post-Liver Transplant Recurrent Genotype 1 HCV.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Cost-Benefit Analysis; Cyclopropanes; Drug | 2016 |
[A Case of Peritoneal Metastasis of Breast Cancer Diagnosed by Laparoscopic-Assisted Right Hemicolectomy].
Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemothe | 2015 |
First Case in Kazakhstan of Successful Therapy With 2 Consecutive Direct-Acting Antiviral Regimens in a Patient with Hepatitis C Virus-Induced Decompensated Liver Cirrhosis on a Liver Transplant Wait List.
Topics: 2-Naphthylamine; Adult; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Therapy, Combina | 2016 |
[Study of a relationship between a change in the urinary uracil value after a S-1 long-term administration and the recurrence of stomach cancer].
Topics: Aged; Drug Combinations; Female; Health; Humans; Male; Middle Aged; Oxonic Acid; Recurrence; Stomach | 2008 |
Efficacy of postoperative UFT (Tegafur/Uracil) plus PSK therapies in elderly patients with resected colorectal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therap | 2009 |
[A case report--complete disappearance of multiple intrahepatic recurrences and portal thrombus in a case of hepatocellular carcinoma treated with UFT-E].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans | 2009 |
[Nineteen years postoperatively, anastrozole, UFT and cyclophosphamide combination therapy remained effective against recurrent hormone responsive breast cancer with intraabdominal lymphnode, pleural, skin and bone metastases in old age following sixteen-
Topics: Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; B | 2009 |
Relative clinical and hematologic effects of concentrated liver extract, synthetic folic acid and synthetic 5-methyl uracil in the treatment of macrocytic anemias in relapse.
Topics: Anemia; Anemia, Macrocytic; Folic Acid; Liver; Liver Extracts; Recurrence; Uracil; Vitamin B Complex | 1947 |
[Successful management with S-1 of recurrent gastric cancer after adjuvant chemotherapy with paclitaxel/UFT].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Combinations; Dru | 2010 |
[A case of fluoropyrimidine-resistant recurrent colon cancer successfully treated with weekly administration of irinotecan].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoembryonic Antigen; Coloni | 2010 |
[A case of marked efficacy of low-dose UFT against metastatic bladder cancer].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 2011 |
[A case of lung metastases after surgery for colon cancer demonstrating complete response for more than six years after treatment with UFT/LV].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Humans; Leucovorin; Lung | 2011 |
[A retrospective study of UFT and oral leucovorin plus PSK combination adjuvant chemotherapy in patients with stage III colon cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Leucovori | 2012 |
Inhibitory activity of CX-659S, a novel diaminouracil derivative, against the rebound phenomenon following withdrawal of corticosteroid therapy for chronic contact hypersensitivity responses.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Chronic Disease; Dermatitis, Atopic; Der | 2003 |
[Two cases of recurrent colorectal cancer treated successfully with folinate/tegafur/uracil (UFT/LV) chemotherapy on an outpatient basis].
Topics: Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Colorectal | 2008 |
[Treatment of refractory pyodermas with rifampicin in combination with diucifon].
Topics: Adolescent; Adult; Aged; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle | 1982 |
6-Methyluracil excretion in 2-methylacetoacetyl-CoA thiolase deficiency and in two children with an unexplained recurrent ketoacidaemia.
Topics: Acetyl-CoA C-Acetyltransferase; Acetyl-CoA C-Acyltransferase; Child; Child, Preschool; Female; Human | 1994 |
[Successful inhibition of bladder tumor recurrence by oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional | 1994 |
[Acute anal fissures in puerperants].
Topics: Actihaemyl; Acute Disease; Anti-Ulcer Agents; Cicatrix; Female; Fissure in Ano; Follow-Up Studies; G | 1999 |
[Antioxidant therapy with xymedon of patients with chronic osteomyelitis].
Topics: Adjuvants, Immunologic; Animals; Antioxidants; Chronic Disease; Free Radicals; Humans; Lipid Peroxid | 2000 |
[Economic effectiveness of antirecurrence treatment of peptic ulcer].
Topics: Adult; Anabolic Agents; Cost-Benefit Analysis; Drug Evaluation; Female; Humans; Male; Methandrosteno | 1976 |
[Therapy of syphilis].
Topics: Adult; Female; Humans; Recurrence; Syphilis; Syphilis Serodiagnosis; Uracil; USSR | 1975 |
[Immediate and long-term results of the combined treatment of patients with extensive destructive tuberculosis of the lungs].
Topics: Adult; Ethionamide; Female; Follow-Up Studies; Glucocorticoids; Humans; Isoniazid; Male; Middle Aged | 1989 |
[Improved treatment of patients with recurrent secondary syphilis].
Topics: Adolescent; Adult; Antibody Formation; Drug Evaluation; Drug Therapy, Combination; Female; Humans; I | 1988 |
[Neutrophil chemotactic activity in syphilis patients during treatment].
Topics: Adjuvants, Immunologic; Bismuth; Chemotaxis, Leukocyte; Drug Combinations; Drug Therapy, Combination | 1985 |
[Combined therapy of syphilis patients based on the characteristics of their immunological status].
Topics: Antibody Formation; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunity, Cellular; Levami | 1985 |
[Use of specific gamma-globulin in the treatment of erysipelas and the prevention of relapse].
Topics: Adolescent; Adult; Aged; Diphenhydramine; Erysipelas; Female; gamma-Globulins; Humans; Injections, I | 1973 |
[Treatment to prevent recurrence of gastric and duodenal ulcers in industrial conditions].
Topics: Adult; Duodenal Ulcer; Female; Humans; Male; Methandrostenolone; Middle Aged; Occupational Medicine; | 1972 |